08/30/2026
Medicare & GLP-1 Medications: A New Option
Starting July 1, 2026, CMS launched a new program that may help some Medicare beneficiaries access certain GLP-1 medications for weight management.
Here are the details:
⭐️ Eligible medications include Wegovy®, Foundayo®, and certain Zepbound® KwikPen® formulations
⭐️ Eligible participants pay $50 per month
⭐️ The program runs through December 31, 2027
⭐️ Your doctor must determine if you qualify and submit the required authorization
⭐️ This is a CMS program, not a Medicare Advantage or Part D plan benefit, but you must be enrolled in Part D to be eligible.
Interested in finding out if you may qualify? Start by talking with your doctor about whether a GLP-1 medication is right for you.